GHRP-6 is listed by name alongside GHRP-1, GHRP-2, GHRP-3, GHRP-4, GHRP-5, hexarelin (examorelin), and alexamorelin
These effects appear to arise indirectly through vascular support, inflammation control, and cellular protection rather than direct neurotransmitter stimulation
The injectable formulation requires once-weekly subcutaneous administration, similar to Tirzepatide
371 Compared with single-agent treatment, the combination of APG-115 and radiation strongly inhibits tumor growth in vivo
This post is intended for informational purposes only and is not a substitute for professional medical advice
The FTPP peptide adipotide research targets this same visceral compartment through entirely different mechanisms, providing additional context for researchers evaluating their options